stage iv disease

Showing 1 - 1 of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC, Stage IV Disease, EGFR Unknown or Wild-type Trial (Tivozanib, Erlotinib, Standard of Care treatment)

Withdrawn
  • Non-small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jul 23, 2013